SpinaFX Wins FDA IDE for Triojection Lumbar Disc Therapy
TORONTO, June 9, 2026 SpinaFX Medical has achieved a major regulatory milestone after receiving U.S. Food and Drug Administration...
Pain Management
Advertisement
Multi Radiance Medical Expands FDA-Cleared Laser Therapy Indications
SOLON, Ohio, June 10, 2026 Multi Radiance Medical announced that the U.S. Food and Drug Administration (FDA) has granted...
Vertanical’s Exilby Wins First European Approval for Chronic Pain
GRÄFELFING, Germany – June 9, 2026 VERTANICAL has achieved a major milestone in chronic pain treatment after receiving Germany’s...
Levicept’s LEVI-04 Shows Disease-Modifying Potential in Osteoarthritis
SANDWICH, UK, June 3, 2026 Levicept Ltd announced new data from its Phase 2 clinical trial of LEVI-04, a...
Tonix Highlights Real-World Opioid Burden in Fibromyalgia at ASCP 2026
BERKELEY HEIGHTS, N.J., May 28, 2026 Tonix Pharmaceuticals presented new real-world data at the 2026 American Society of Clinical...
Advertisements
Consano Bio Starts Phase 1 Trial for C-1101 Therapy
BURLINGTON, Massachusetts, May 26, 2026 Consano Bio, Inc., a clinical-stage biotechnology company focused on developing innovative therapies for painful...
Contineum Therapeutics Reports Positive PIPE-791 Data
SAN DIEGO, April 30, 2026 Contineum Therapeutics, Inc. announced positive topline results from its Phase 1b clinical trial of...
Autonomix Reports Rapid, Durable Pain Relief in Pancreatic Cancer
THE WOODLANDS, Texas | January 9, 2026 — Autonomix Medical, Inc. has reported compelling proof-of-concept (PoC) clinical data demonstrating...
NEXTBIOMEDICAL Launches U.S. Pivotal Trial for Nexsphere-F™ in Knee OA
SEOUL, South Korea, Oct. 13, 2025 — NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), a South Korea-based innovative medical device company,...
Bio-Thera and STADA Expand Alliance with Biosimilars-Tocilizumab
August 22, 2025 — Bio-Thera Solutions and STADA Arzneimittel have announced the expansion of their biosimilars partnership to include...
Advertisement
